Patents by Inventor Kotaro Kodama

Kotaro Kodama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230330081
    Abstract: Provided is a pharmaceutical composition for treating a tumor, comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxyl-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or its pharmaceutically acceptable salt, which is to be administered in combination with a PD-1 antagonist.
    Type: Application
    Filed: October 26, 2021
    Publication date: October 19, 2023
    Inventors: Taisuke HOSHI, Yu KATO, Yoichi OZAWA, Satoshi KAWANO, Kotaro KODAMA, Saori MIYANO
  • Publication number: 20230303014
    Abstract: A fender liner that is to be placed in a curved shape along a periphery of a tire of a vehicle includes: a first foam layer that is formed by a first foam body; and a mixed layer that includes a first non-woven fabric and a second foam body that is foamed inside the first non-woven fabric, wherein the first foam body forming the first foam layer is seamless with the second foam body included in the mixed layer.
    Type: Application
    Filed: May 4, 2023
    Publication date: September 28, 2023
    Applicant: AGC Inc.
    Inventors: Takamichi SHIMOSAKA, Takashi TAKADA, Kotaro KODAMA, Yukihiro FUJIWARA
  • Publication number: 20230286450
    Abstract: A fender liner that is to be placed in a curved shape along a periphery of a tire of a vehicle includes: a first foam layer that is formed by a first foam body; and a second foam layer that is formed by a second foam body, the second foam body having a composition different from a composition of the first foam body, wherein the first foam layer and the second foam layer are arranged in a circumferential direction of the tire.
    Type: Application
    Filed: May 22, 2023
    Publication date: September 14, 2023
    Applicant: AGC Inc.
    Inventors: Takamichi SHIMOSAKA, Takashi TAKADA, Kotaro KODAMA, Yukihiro FUJIWARA
  • Publication number: 20210349097
    Abstract: Biomarkers are provided that predict whether a human subject having a renal cell carcinoma is responsive to a combination therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof (e.g., lenvatinib mesylate) and everolimus. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for and treating a subject having, suspected of having, or at risk of developing a renal cell carcinoma.
    Type: Application
    Filed: October 2, 2019
    Publication date: November 11, 2021
    Inventors: Yasuhiro Funahashi, Yukinori Minoshima, Michio Kanekiyo, Masahiro Matsuki, Yusuke Adachi, Kotaro Kodama
  • Publication number: 20210123919
    Abstract: Biomarkers are provided that are predictive of a subject's responsiveness to a combination therapy comprising lenvatinib compound and a PD-1 antagonist. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing cancer.
    Type: Application
    Filed: May 13, 2019
    Publication date: April 29, 2021
    Applicants: Merck Sharp & Dohme Corp., Eisai R&D Management Co., Ltd.
    Inventors: Yasuhiro FUNAHASHI, Kotaro KODAMA, Ryo DAIRIKI, Yukinori MINOSHIMA
  • Patent number: 7781452
    Abstract: A compound represented by the following general formula (1), or a salt or hydrate thereof: [Formula 1] wherein R1 represents a C1-C6 alkyl group or C2-C6 alkynyl group which may be substituted, or a phenyl group which may be substituted, R2 represents a hydrogen atom or a C1-C6 alkyl group, R3 represents methyl or ethyl group, R4 represents a C1-C6 alkyl group, R5 represents a hydrogen atom, provided that a compound wherein R1 is a C1-C6 alkyl group unsubstituted or substituted with a halogen atom and R2 is a hydrogen atom is excluded.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: August 24, 2010
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Shuhei Miyazawa, Hitoshi Harada, Hideaki Fujisaki, Atsuhiko Kubota, Kotaro Kodama, Junichi Nagakawa, Kiyoshi Oketani, Nobuhisa Watanabe
  • Publication number: 20060167041
    Abstract: A compound represented by the following general formula (1), or a salt or hydrate thereof: [Formula 1] wherein R1 represents a C1-C6 alkyl group or C2-C6 alkynyl group which may be substituted, or a phenyl group which may be substituted, R2 represents a hydrogen atom or a C1-C6 alkyl group, R3 represents methyl or ethyl group, R4 represents a C1-C6 alkyl group, R5 represents a hydrogen atom, provided that a compound wherein R1 is a C1-C6 alkyl group unsubstituted or substituted with a halogen atom and R2 is a hydrogen atom is excluded.
    Type: Application
    Filed: March 22, 2006
    Publication date: July 27, 2006
    Inventors: Shuhei Miyazawa, Hitoshi Harada, Hideaki Fujisaki, Atsuhiko Kubota, Kotaro Kodama, Junichi Nagakawa, Kiyoshi Oketani, Nobuhisa Watanabe
  • Publication number: 20050272764
    Abstract: A compound represented by the following general formula (1), or a salt or hydrate thereof: wherein R1 represents a C1-C6 alkyl group or C2-C6 alkynyl group which may be substituted, or a phenyl group which may be substituted, R2 represents a hydrogen atom or a C1-C6 alkyl group, R3 represents methyl or ethyl group, R4 represents a C1-C6 alkyl group, R5 represents a hydrogen atom, provided that a compound wherein R1 is a C1-C6 alkyl group unsubstituted or substituted with a halogen atom and R2 is a hydrogen atom is excluded.
    Type: Application
    Filed: April 21, 2005
    Publication date: December 8, 2005
    Inventors: Shuhei Miyazawa, Hitoshi Harada, Hideaki Fujisaki, Atsuhiko Kubota, Kotaro Kodama, Junichi Nagakawa, Kiyoshi Oketani, Nobuhisa Watanabe